- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02581046
Effect of the Timing of Cataract Surgery on Complications in Patients With Bilateral Congenital Cataracts
Effect of the Timing of Lens-removal Cataract Surgery on Postoperative Complications Rate Among Patients With Bilateral Congenital Cataracts
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
- Droga: Dexametasona subconjuntival y anestesia general
- Procedimiento: Phacomulsification lens removal cataract surgery without Intraocular lens(IOL) implantation at the age of 3month of the patients
- Procedimiento: Phacomulsification lens removal cataract surgery without Intraocular lens(IOL) implantation at the age of 6 month of the patients
Descripción detallada
Congenital cataract is a priority of Vision 2020: the Right to Sight, the global initiative to reduce the world's burden of avoidable blindness, because it is an important treatable cause of visual handicap in childhood throughout the world. Successful management of childhood cataract is dependent on individualized treatment strategies and postoperative supervision for adverse complication is also essential. The timing of surgery of childhood cataract depends on the etiology and on the degree of visual interference. Severe bilateral cataracts with significant obstruction of the visual axis must be treated and surgery is recommended as soon as possible after discovery.
Several previous studies claimed that ideally cataracts should be removed before 3 months of age, while the result of recent researches shows that too early intervention for cataract surgery seems aggressive and would cause serious complications, which might cause poor long-term visual outcomes. Therefore, in order to control childhood blindness and severe visual impairment in China, it is of great importance to ensure that pediatric patients with cataract could have good timing of surgery, postoperative rigorous supervision, accurate optical rehabilitation and comprehensive treatment of amblyopia.
In this trial, we aimed to compare the difference of postoperative outcome between surgical timing at age of 3 month and 6 month. Patients enrolled into the study will be followed for two year and will have study visits at 1 day, 1 week, 1 month, 3 months, 6 months, 9 months, 12 months, 18months and 24months after cataract surgery.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Guangdong
-
Guangzhou, Guangdong, Porcelana, 510060
- Zhognshan Ophthalmic Center, Sun Yat-sen University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Children diagnosis with bilateral congenital cataract for entire lens without other ocular abnormality
- No more than 3 month old
- Have signed a consent form
- Can be followed
Exclusion Criteria:
- Children not identified with congenital cataract
- Have not signed consent form
- Be not able to be followed
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: 3 month surgical group
Phacoemulsification pediatric cataract surgery is performed at the age of 3 month of patients without IOL implantation.
|
Todos los pacientes recibieron dexametasona subconjuntival (2 mg) durante la cirugía y todas las cirugías se realizaron bajo anestesia general.
The surgical timing of phacoemulsification is perform at the age of 3 month of the patients.
During Phacoemulsification, viscoelastic materials and anterior lens capsule are used to protect corneal endothelial cells.
|
|
Experimental: 6 month surgical group
Phacoemulsification pediatric cataract surgery is performed at the age of 3 month of patients without IOL implantation..
|
Todos los pacientes recibieron dexametasona subconjuntival (2 mg) durante la cirugía y todas las cirugías se realizaron bajo anestesia general.
The surgical timing of phacoemulsification is perform at the age of 6 month of the patients.
During Phacoemulsification, viscoelastic materials and anterior lens capsule are used to protect corneal endothelial cells.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Change from baseline in the central subfield thickness (CST) measured by Optical Coherence Tomography(OCT)
Periodo de tiempo: during surgery,postoperation time:1day,1week,1month,3month,6month,9month,12month,18month,24month
|
during surgery,postoperation time:1day,1week,1month,3month,6month,9month,12month,18month,24month
|
|
Change from baseline in the thickness of the inner retinal layer regions measured by Optical Coherence Tomography(OCT)
Periodo de tiempo: during surgery,postoperation time:1day,1week,1month,3month,6month,9month,12month,18month,24month
|
during surgery,postoperation time:1day,1week,1month,3month,6month,9month,12month,18month,24month
|
|
Change from baseline in the thickness of the outer retinal layer regions measured by Optical Coherence Tomography(OCT)
Periodo de tiempo: during surgery,postoperation time:1day,1week,1month,3month,6month,9month,12month,18month,24month
|
during surgery,postoperation time:1day,1week,1month,3month,6month,9month,12month,18month,24month
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Number of participants with abnormal intraocular pressure or diagnosis with secondary glaucoma
Periodo de tiempo: 2 year after surgery
|
2 year after surgery
|
|
Number of participants undergoing Nd:YAG laser capsulotomy due to severe posterior capsular opacification(PCO)
Periodo de tiempo: 2 year after surgery
|
2 year after surgery
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Publicaciones y enlaces útiles
Publicaciones Generales
- Zetterstrom C, Lundvall A, Kugelberg M. Cataracts in children. J Cataract Refract Surg. 2005 Apr;31(4):824-40. doi: 10.1016/j.jcrs.2005.01.012.
- Whitman MC, Vanderveen DK. Complications of pediatric cataract surgery. Semin Ophthalmol. 2014 Sep-Nov;29(5-6):414-20. doi: 10.3109/08820538.2014.959192.
- Mansouri B, Stacy RC, Kruger J, Cestari DM. Deprivation amblyopia and congenital hereditary cataract. Semin Ophthalmol. 2013 Sep-Nov;28(5-6):321-6. doi: 10.3109/08820538.2013.825289.
- Lenhart PD, Courtright P, Wilson ME, Lewallen S, Taylor DS, Ventura MC, Bowman R, Woodward L, Ditta LC, Kruger S, Haddad D, El Shakankiri N, Rai SK, Bailey T, Lambert SR. Global challenges in the management of congenital cataract: proceedings of the 4th International Congenital Cataract Symposium held on March 7, 2014, New York, New York. J AAPOS. 2015 Apr;19(2):e1-8. doi: 10.1016/j.jaapos.2015.01.013.
- Magli A, Forte R, Rombetto L. Long-term outcome of primary versus secondary intraocular lens implantation after simultaneous removal of bilateral congenital cataract. Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):309-14. doi: 10.1007/s00417-012-1979-7. Epub 2012 Mar 14.
- Young MP, Heidary G, VanderVeen DK. Relationship between the timing of cataract surgery and development of nystagmus in patients with bilateral infantile cataracts. J AAPOS. 2012 Dec;16(6):554-7. doi: 10.1016/j.jaapos.2012.08.008.
- Bayoumi NH. Surgical Management of Glaucoma After Congenital Cataract Surgery. J Pediatr Ophthalmol Strabismus. 2015 Jul-Aug;52(4):213-20. doi: 10.3928/01913913-20150414-11. Epub 2015 Apr 17.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
- Enfermedades de los ojos
- Enfermedades del cristalino
- Catarata
- Efectos fisiológicos de las drogas
- Agentes Autonómicos
- Agentes del sistema nervioso periférico
- Agentes antiinflamatorios
- Agentes antineoplásicos
- Antieméticos
- Agentes Gastrointestinales
- Glucocorticoides
- Hormonas
- Hormonas, sustitutos hormonales y antagonistas hormonales
- Agentes Antineoplásicos Hormonales
- Dexametasona
Otros números de identificación del estudio
- CCPMOH2010-China7
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .